584
Views
18
CrossRef citations to date
0
Altmetric
Review

Vitamin D in older population: new roles for this ‘classic actor’?

, , , &
Pages 215-232 | Received 05 Nov 2009, Accepted 17 Feb 2010, Published online: 01 Jun 2010

References

  • HolickMF. Vitamin D deficiency. N Engl J Med 2007;357:266–281.
  • MalabananA, VeronikisIE, HolickMF. Redefining vitamin D insufficiency. Lancet 1998;351:805–806.
  • HolickMF. MrOs is deficient. J Clin Endocrinol Metab 2009;94:1092–1093.
  • HolickMF, ChenTC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008;87:1080S–1086S.
  • OudshoornC, van der CammenTJ, McMurdoME, van LeeuwenJP, ColinEM. Ageing and vitamin D deficiency: effects on calcium homeostasis and considerations for vitamin D supplementation. Br J Nutr 2009;101:1597–1606.
  • MaggioD, CherubiniA, LauretaniF, RussoRC, BartaliB, PierandreiM, RuggieroC, MacchiaruloMC, GiorginoR, MinisolaS, et al25(OH)D Serum levels decline with age earlier in women than in men and less efficiently prevent compensatory hyperparathyroidism in older adults. J Gerontol A Biol Sci Med Sci 2005;60:1414–1419.
  • OrwollE, NielsonCM, MarshallLM, LambertL, HoltonKF, HoffmanAR, Barrett-ConnorE, ShikanyJM, DamT, CauleyJA; Osteoporotic Fractures in Men (MrOS) Study Group. Vitamin D deficiency in older men. J Clin Endocrinol Metab 2009;94:1214–1222.
  • EnsrudKE, TaylorBC, PaudelML, et alSerum 25-hydroxyvitamin D levels and rate of hip bone loss in older men. J Clin Endocrinol Metab 2009;94:2773–2780.
  • SetonM, JacksonV, LasserKE, DoppeltS, Pierre-JacquesM, ConnellyM. Low 25-hydroxyvitamin D and osteopenia are prevalent in persons > or  = 55 yr with fracture at any site: a prospective, observational study of persons fracturing in the community. J Clin Densitom 2005;8:454–460.
  • NurmiI, KaukonenJP, LüthjeP, NaboulsiH, TanninenS, KatajaM, KallioML, LeppilampiM. Half of the patients with an acute hip fracture suffer from hypovitaminosis D: a prospective study in southeastern Finland. Osteoporos Int 2005;16:2018–2024.
  • BoxerRS, DauserDA, WalshSJ, HagerWD, KennyAM. The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure. J Am Geriatr Soc 2008;56:454–461.
  • WichertsIS, van SchoorNM, BoekeAJ, VisserM, DeegDJ, SmitJ, KnolDL, LipsP. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 2007;92:2058–2065.
  • VisserM, DeegDJ, LipsP; Longitudinal Aging Study Amsterdam. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003;88:5766–5772.
  • SnijderMB, van SchoorNM, PluijmSM, van DamRM, VisserM, LipsP. Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab 2006;91:2980–2985.
  • PilzS, DobnigH, NijpelsG, HeineRJ, StehouwerCD, SnijderMB, van DamRM, DekkerJM. Vitamin D and mortality in older men and women. Clin Endocrinol (Oxf) 2009;71:666–672.
  • LiYC. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem 2003;88:327–331.
  • AchingerSG, AyusJC. The role of vitamin D in left ventricular hypertrophy and cardiac function. Kidney Int Suppl 2005;95:S37–S42.
  • PilzS, MärzW, WellnitzB, SeelhorstU, Fahrleitner-PammerA, DimaiHP, BoehmBO, DobnigH. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008;93:3927–3935.
  • LiuE, MeigsJB, PittasAG, McKeownNM, EconomosCD, BoothSL, JacquesPF. Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 2009;139:329–334.
  • KnektP, LaaksonenM, MattilaC, HärkänenT, MarniemiJ, HeliövaaraM, RissanenH, MontonenJ, ReunanenA. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 2008;19:666–671.
  • SteneLC, JonerG. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am J Clin Nutr 2003;78:1128–1134.
  • YinL, RaumE, HaugU, ArndtV, BrennerH. Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk. Cancer Epidemiol 2009;33:435–445.
  • YinL, GrandiN, RaumE, HaugU, ArndtV, BrennerH. Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther 2009;30:113–125.
  • NgK, WolpinBM, MeyerhardtJA, WuK, ChanAT, HollisBW, GiovannucciEL, StampferMJ, WillettWC, FuchsCS. Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br J Cancer 2009;101:916–923.
  • FreedmanDM, LookerAC, ChangSC, GraubardBI. Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 2007;99:1594–1602.
  • NnoahamKE, ClarkeA. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008;37:113–119.
  • MerlinoLA, CurtisJ, MikulsTR, CerhanJR, CriswellLA, SaagKG. Vitamin D intake is inversely associated with rheumatoid arthritis. Arthritis Rheum 2004;50:72–77.
  • MüllerK, KriegbaumNJ, BaslundB, SørensenOH, ThymannM, BentzenK. Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol 1995;14:397–400.
  • HoogendijkWJ, LipsP, DikMG, DeegDJ, BeekmanAT, PenninxBW. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 2008;65:508–512.
  • SlininY, PaudelML, TaylorBC, FinkHA, IshaniA, CanalesMT, YaffeK, Barrett-ConnorE, OrwollES, ShikanyJM, et alOsteoporotic Fractures in Men (MrOS) Study Research Group. 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology 2010;74:33–41.
  • AnnweilerC, AllaliG, AllainP, BridenbaughS, SchottAM, KressigRW, BeauchetO. Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol 2009;16:1083–1089.
  • MungerKL, LevinLI, HollisBW, HowardNS, AscherioA. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296:2832–2838.
  • AvenellA, GillespieWJ, GillespieLD, O'ConnellD. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2009;2: CD000227.
  • Bischoff-FerrariHA, Dawson-HughesB, BaronJA, BurckhardtP, LiR, SpiegelmanD, SpeckerB, OravJE, WongJB, StaehelinHB, et alCalcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr 2007;86:1780–1790.
  • Dawson-HughesB, HarrisSS, KrallEA, DallalGE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670–676.
  • LipsP, GraafmansWC, OomsME, BezemerPD, BouterLM. Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med 1996;124:400–406.
  • AnnweilerC, SchottAM, BerrutG, FantinoB, BeauchetO. Vitamin d-related changes in physical performance: a systematic review. J Nutr Health Aging 2009;13:893–898.
  • Bischoff-FerrariHA, Dawson-HughesB, StaehelinHB, OravJE, StuckAE, TheilerR, WongJB, EgliA, KielDP, HenschkowskiJ. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009;339:3692.
  • GillespieLD, RobertsonMC, GillespieWJ, LambSE, GatesS, CummingRG, RoweBH. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2009;15: CD007146.
  • AutierP, GandiniS. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007;167:1730–1737.
  • PalmerSC, McGregorDO, MacaskillP, CraigJC, ElderGJ, StrippoliGF. Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med 2007;147:840–853.
  • AvenellA, CookJA, MacLennan, G.S., McPhersonGC; RECORD trial group. Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing 2009;38:606–609.
  • Wactawski-WendeJ, KotchenJM, AndersonGL, et alCalcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006;354:684–696.
  • VijayakumarS, MehtaRR, BoernerPS, PackianathanS, MehtaRG. Clinical trials involving vitamin D analogs in prostate cancer. Cancer J 2005;11:362–373.
  • YamshchikovAV, DesaiNS, BlumbergHM, ZieglerTR, TangprichaV. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract 2009;15:438–449.
  • WejseC, GomesVF, RabnaP, GustafsonP, AabyP, LisseIM, AndersenPL, GlerupH, SodemannM. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009;179:843–850.
  • DIPART (Vitamin D Individual Patient Analysis of Randomized Trials) Group. Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ 2010;340:b5463.
  • SimpsonRU, ThomasGA, ArnoldAJ. Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem 1985;260:8882–8891.
  • DamTT, von MühlenD, Barrett-ConnorEL. Sex-specific association of serum vitamin D levels with physical function in older adults. Osteoporos Int 2009;20:751–760.
  • HicksGE, ShardellM, MillerRR, BandinelliS, GuralnikJM, CherubiniA, LauretaniF, FerrucciL. Associations between vitamin D status and pain in older adults: the Invecchiare in Chianti study. J Am Geriatr Soc 2008;56:785–791.
  • PlotnikoffGA, QuigleyJM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 2003;78:1463–1470.
  • Bischoff-FerrariHA, DietrichT, OravEJ, HuFB, ZhangY, KarlsonEW, Dawson-HughesB. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or  = 60 y. Am J Clin Nutr 2004;80:752–758.
  • ShardellM, HicksGE, MillerRR, KritchevskyS, AndersenD, BandinelliS, CherubiniA, FerrucciL. Association of low vitamin D levels with the frailty syndrome in men and women. J Gerontol A Biol Sci Med Sci 2009;64:69–75.
  • HoustonDK, CesariM, FerrucciL, CherubiniA, MaggioD, BartaliB, JohnsonMA, SchwartzGG, KritchevskySB. Association between vitamin D status and physical performance: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2007;62:440–446.
  • ViethR. Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol 2004;89:575–579.
  • Bischoff-FerrariHA, Dawson-HughesB, WillettWC, StaehelinHB, BazemoreMG, ZeeRY, WongJB. Effect of Vitamin D on falls: a meta-analysis. JAMA 2004;291:1999–2006.
  • Bischoff-FerrariHA, WillettWC, WongJB, GiovannucciE, DietrichT, Dawson-HughesB. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293:2257–2264.
  • PietschmannP, SchernthanerG, WoloszczukW. Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications. Diabetologia 1998;31:892–895.
  • IsaiaG, GiorginoR, AdamiS. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care 2001;24:1496.
  • BoucherBJ, MannanN, NoonanK, HalesCN, EvansSJ. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 1995;38:1239–1245.
  • ChiuKC, ChuA, GoVL, SaadMF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79:820–825.
  • LittorinB, BlomP, SchölinA, ArnqvistHJ, BlohméG, BolinderJ, Ekbom-SchnellA, ErikssonJW, GudbjörnsdottirS, NyströmL, et alLower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006;49:2847–2852.
  • The EURODIAB Substudy 2 Study Group. Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. Diabetologia 1999;42:51–54.
  • HypponenE, LaaraE, ReunanenA, JarvelinMR, VirtanenSM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001;358:1500–1503.
  • ScraggR, SowersM, BellC. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004;27:2813–2818.
  • FordE S., AjaniUA, McGuireLC, LiuS. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005;28:1228–1230.
  • BoucherBJ. Inadequate vitamin D status: does it contribute to the disorders comprising syndrome ‘X’. Br J Nutr 1998;79:315–327.
  • ZeitzU, WeberK, SoegiartoDW, WolfE, BallingR, ErbenRG. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 2003;17:509–511.
  • WaltersMR. Newly identified actions of the vitamin D endocrine system. Endocr Rev 1992;13:719–764.
  • BeaulieuC, KestekianR, HavrankovaJ, Gascon-BarreM. Calcium is essential in normalizing intolerance to glucose that accompanies vitamin D depletion in vivo. Diabetes 1993;42:35–43.
  • IshidaH, SeinoY, SeinoYS, TsudaK, TakemuraJ, NishiS, IshizukaS, ImuraH. Effect of 1,25-dihydroxyvitamin D3 on pancreatic B and D cell function. Life Sci 1983;33:1779–1786.
  • BorissovaAM, TankovaT, KirilovG, DakovskaL, KovachevaR. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003;57:258–261.
  • BuellJS, Dawson-HughesB. Vitamin D and neurocognitive dysfunction: Preventing “D”ecline?Mol Aspects Med 2008;29:415–422.
  • McGrathJ, SeltenJP, ChantD. Long-term trends in sunshine duration and its association with schizophrenia birth rates and age at first registration data from Australia and the Netherlands. Schizophr Res 2002;54:199–212.
  • GlothFMIII, AlamW, HollisB. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal effective disorder. J Nutr Health Aging 1999;3:5–7.
  • Soilu-HänninenM, LaaksonenM, LaitinenI, ErälinnaJP, LiliusEM, MononenI. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatry 2008;79:152–157.
  • LeeDM, TajarA, UlubaevA, PendletonN, O'NeillTW, O'ConnorDB, BartfaiG, BoonenS, BouillonR, CasanuevaFF, et alEMAS study group. Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J Neurol Neurosurg Psychiatry 2009;80:722–729.
  • MillerJW. Vitamin D and cognitive function in older adults: are we concerned about vitamin D-mentia?Neurology 2010;74:13–15.
  • NagpalS, NaS, RathnachalamR. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005;26:662–687.
  • MathieuC, AdoriniL. The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med 2002;8:174–179.
  • ApperlyFL. The relation of solar radiation to cancer mortality in North America. Cancer Res 1941;1:191–195.
  • GarlandCF, ComstockGW, GarlandFC, HelsingKJ, ShawEK, GorhamED. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 1989;2:1176–1178.
  • GiovannucciE, LiuY, RimmEB, HollisBW, FuchsCS, StampferMJ, WillettWC. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006;98:451–459.
  • GarlandC, ShekelleRB, Barrett-ConnorE, CriquiMH, RossofAH, OglesbyP. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 2005;9:307–309.
  • LappeJM, Travers-GustafsonD, DaviesKM, ReckerRR, HeaneyRP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007;85:1586–1591.
  • KamenD, AranowC. Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol 2008;20:532–537.
  • JahnsenJ, FalchJA, MowinckelP, AadlandE. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol 2002;37:192–199.
  • CostenbaderKH, FeskanichD, HolmesM, KarlsonEW, Benito-GarciaE. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 2008;67:530–535.
  • O'ReganS, ChesneyRW, HamstraA, EismanJA, O'GormanAM, DelucaHF. Reduced serum 1,25-(OH)2 vitamin D3 levels in prednisone-treated adolescents with systemic lupus erythematosus. Acta Paediatr Scand 1979;68:109–111.
  • BultinkIE, LemsWF, KostensePJ, DijkmansBA, VoskuylAE. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 2005;52:2044–2050.
  • TeichmannJ, LangeU, StrackeH, FederlinK, BretzelRG. Bone metabolism and bone mineral density of systemic lupus erythematosus at the time of diagnosis. Rheumatol Int 1999;18:137–140.
  • HuismanAM, WhiteKP, AlgraA, HarthM, ViethR, JacobsJW, BijlsmaJW, BellDA. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol 2001;28:2535–2539.
  • ChenS, SimsGP, ChenXX, GuYY, ChenS, LipskyPE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007;179:1634–1647.
  • OrbachH, Zandman-GoddardG, AmitalH, BarakV, SzekaneczZ, SzucsG, DankoK, NagyE, CsepanyT, CarvalhoJF, et alNovel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci 2007;1109:385–400.
  • SembaRD, HoustonDK, BandinelliS, SunK, CherubiniA, CappolaAR, GuralnikJM, FerrucciL. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr 2010;64:203–209.
  • GindeAA, ScraggR, Schwartz, RS, CamargoCAJr.Prospective study of serum 25-hydroxyvitamin d level, cardiovascular disease mortality, and all-cause mortality in older U.S. Adults. J Am Geriatr Soc 2009;57:1595–1603.
  • LeeJH, O'KeefeJH, BellD, HensrudDD, HolickMF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?J Am Coll Cardiol 2008;52:1949–1956.
  • NemerovskiCW, DorschMP, SimpsonRU, BoneHG, AaronsonKD, BleskeBE. Vitamin D and cardiovascular disease. Pharmacotherapy 2009;29:691–708.
  • DobnigH, PilzS, ScharnaglH, RennerW, SeelhorstU, WellnitzB, KinkeldeiJ, BoehmBO, WeihrauchG, MaerzW. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340–1349.
  • VisserM, DeegDJ, PutsMT, SeidellJC, LipsP. Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Am J Clin Nutr 2006;84:616–622.
  • MelamedML, MichosE, PostW, AstorB. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008;168:1629–1637.
  • WangTJ, PencinaMJ, BoothSL, JacquesPF, IngelssonE, LanierK, BenjaminEJ, D'AgostinoRB, WolfM, VasanRS. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503–511.
  • ArenasMD, Alvarez-UdeF, GilMT, SorianoA, EgeaJJ, MillánI, AmoedoML, MurayS, CarretónMA. Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units. Nephrol Dial Trasplant 2006;21:1663–1668.
  • BhuttoA, MorleyJE. The clinical significance of gastrointestinal changes with aging. Curr Opin Clin Nutr Metab Care 2008;11:651–660.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.